Thursday, December 18, 2025 | 12:11 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Coronavirus fears lead to sudden spike in pneumonia vaccine sales

many people have become sensitised to adult vaccination in the country as we await the first vaccine candidate against the SARS-CoV-2 virus

Coronavirus testing
premium

Pune’s Serum Institute recently got the regulator’s nod to market its indigenously made PCV in India

Sohini Das Mumbai
Anit Roychowdhury (name changed) took a pneumonia shot in his office along with his colleague. Roychowdhury works for a pharma company in Mumbai and has been going to work during the lockdown. He says that they never felt the need to get themselves vaccinated against either flu or pneumonia. However, it was the coronavirus (Covid-19) pandemic that woke them up to the need to protect themselves against respiratory illnesses.

Many like Roychowdhury have become sensitised to adult vaccination in the country as we await the first vaccine candidate against the SARS-CoV-2 virus.
 
As such, there has been a sudden spike